company background image
2M6 logo

Medtronic DB:2M6 Stock Report

Last Price

€77.10

Market Cap

€99.6b

7D

-1.2%

1Y

3.9%

Updated

23 Dec, 2024

Data

Company Financials +

2M6 Stock Overview

Develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. More details

2M6 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance3/6
Financial Health3/6
Dividends5/6

My Notes

Capture your thoughts, links and company narrative

Medtronic plc Competitors

Price History & Performance

Summary of share price highs, lows and changes for Medtronic
Historical stock prices
Current Share PriceUS$77.10
52 Week HighUS$85.96
52 Week LowUS$70.45
Beta0.83
1 Month Change-5.79%
3 Month Change-4.24%
1 Year Change3.88%
3 Year Change-15.39%
5 Year Change-24.04%
Change since IPO169.35%

Recent News & Updates

Recent updates

Shareholder Returns

2M6DE Medical EquipmentDE Market
7D-1.2%-3.3%-2.0%
1Y3.9%-8.5%6.9%

Return vs Industry: 2M6 exceeded the German Medical Equipment industry which returned -8.5% over the past year.

Return vs Market: 2M6 underperformed the German Market which returned 6.9% over the past year.

Price Volatility

Is 2M6's price volatile compared to industry and market?
2M6 volatility
2M6 Average Weekly Movement2.1%
Medical Equipment Industry Average Movement6.7%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.3%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 2M6 has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: 2M6's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
194995,000Geoff Marthawww.medtronic.com

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products.

Medtronic plc Fundamentals Summary

How do Medtronic's earnings and revenue compare to its market cap?
2M6 fundamental statistics
Market cap€99.58b
Earnings (TTM)€4.11b
Revenue (TTM)€31.62b

24.2x

P/E Ratio

3.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2M6 income statement (TTM)
RevenueUS$33.00b
Cost of RevenueUS$11.42b
Gross ProfitUS$21.58b
Other ExpensesUS$17.29b
EarningsUS$4.29b

Last Reported Earnings

Oct 25, 2024

Next Earnings Date

Feb 18, 2025

Earnings per share (EPS)3.34
Gross Margin65.40%
Net Profit Margin13.00%
Debt/Equity Ratio58.0%

How did 2M6 perform over the long term?

See historical performance and comparison

Dividends

3.5%

Current Dividend Yield

85%

Payout Ratio

Does 2M6 pay a reliable dividends?

See 2M6 dividend history and benchmarks
When do you need to buy 2M6 by to receive an upcoming dividend?
Medtronic dividend dates
Ex Dividend DateDec 27 2024
Dividend Pay DateJan 10 2025
Days until Ex dividend4 days
Days until Dividend pay date18 days

Does 2M6 pay a reliable dividends?

See 2M6 dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 10:43
End of Day Share Price 2024/12/20 00:00
Earnings2024/10/25
Annual Earnings2024/04/26

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medtronic plc is covered by 65 analysts. 31 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kadambari DaptardarAccountability Research Corporation
Harshit GuptaAccountability Research Corporation
David ToungArgus Research Company